NCT05590715 · Stalicla SA
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
What this study is about
To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
View original scientific description
To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Participants previously diagnosed with ASD (DSM-5)
- Available well-documented health records within the first 2 years of life
- Participants must have a parent or reliable caregiver who agrees to provide information about the participant
- Participants willing and consenting or assenting to participate.
Exclusion criteria
- Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment.
- If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.
Where
- Phoenix, Arizona
- Sherman Oaks, California
- Miami, Florida
- Miami Lakes, Florida
- Chicago, Illinois
- Columbia, Missouri
- Alamogordo, New Mexico
- Houston, Texas
- Clinton, Utah
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Apr 27, 2026 · Source of record for eligibility and locations